0121 - Sequence # 4015 | CHA2DS2-VASc LV Dysfunction-0121 - Sequence # 4015

Video Transcription

Welcome to the AFib Ablation Registry Case Scenario for January 2021. This case scenario will review Sequence 4015, CHADS 2-VASC LV Dysfunction.  We have a 56-year-old male presenting for a planned AFib ablation procedure secondary to symptomatic persistent AFib that is responding poorly to antiarrhythmic therapy.  The patient's past history also includes a TIA in 2019, hypertension, and heart failure with a documented NYHA Class of 2 and LVEF of 30%, which was documented on an echo from 2019.  How is Sequence 4015, CHADS 2-VASC LV Dysfunction coded for this patient? No or Yes? Here is the information and question for your review.  The answer is number one, no. The target value of any occurrence between 30 days prior to the procedure and the procedure is not met.  For the purpose of the AFib Ablation Registry, Sequence 4015 will be coded Yes when the patient has been diagnosed with LV Dysfunction or has an LVEF less than 40% documented within  30 days of the current procedure. Please code No when such documentation was made greater than 30 days prior to current procedure.  Thank you for viewing the AFib Ablation Monthly Case Scenario for January 2021.

Video Summary

The video discusses a case scenario for the AFib Ablation Registry in January 2021. It focuses on Sequence 4015, CHADS 2-VASC LV Dysfunction, in a 56-year-old male who is scheduled for an AFib ablation procedure due to poor response to antiarrhythmic therapy. The patient's medical history includes a TIA in 2019, hypertension, and heart failure with a NYHA Class of 2 and LVEF of 30% based on an echo from 2019. The question is whether Sequence 4015 should be coded as "no" or "yes" for this patient. The answer is "no" because the target value is not met within 30 days of the procedure.

Keywords

AFib Ablation Registry

Sequence 4015

CHADS 2-VASC LV Dysfunction

AFib ablation procedure

antiarrhythmic therapy